Interim report 2026
Filed with HKEX · Stock code 8037 · · 98 pages · English and Chinese
Summary by 6ix AI
The report includes a condensed consolidated statement of profit or loss, showing revenue and expenses, as well as a statement of financial position outlining the company's assets and liabilities. The company reported a profit for the period, contrasting with a loss in the previous year, indicating a significant improvement in its financial performance. Additionally, the report provides insights into the company's equity changes and cash flows during the same period.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
China Biotech Services Holdings Limited on 6ix
Earlier from China Biotech Services
Later from China Biotech Services
- Notification Letter to Registered Shareholders and Reply Form
- Notification Letter to Non-Registered Shareholders
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- Monthly return of equity issuer on movements in securities for the month ended 31 October 2026
Follow China Biotech Services into a list and get an email when it puts out news.
Follow China Biotech Services